FLOXINOR 20% ORAL

Indications

• Lead poisoning
• Mercury poisoning
• Cadmium poisoning
• Hypercalcemia
• Diagnostic aid in certain medical tests

Dosage

Children: Refer to the BNF for Children for appropriate dosing based on the condition and age of the child.

Adults: Refer to the specific guidelines in the BNF for appropriate dosing based on the condition being treated.

Mechanism of action

EDTA2Na acts by chelating divalent and trivalent metal ions through the formation of stable, water-soluble complexes. The chelation process involves the formation of coordinate covalent bonds between the electron-rich donor atoms of EDTA and the metal ions, effectively reducing the bioavailability and toxicity of the metals. This mechanism enhances the renal excretion of the metal complexes, thus decreasing their concentration in the body.

Pharmacodynamics

The pharmacodynamic effects of EDTA2Na are primarily related to its chelating activity, leading to the reduction of metal toxicity and the alleviation of symptoms associated with heavy metal exposure. It can also influence the distribution of certain minerals and trace elements within the body, potentially affecting their physiological functions. However, its use can result in the depletion of essential minerals, necessitating careful monitoring and management during treatment.

Pharmacokinetics

EDTA2Na is administered intravenously or intramuscularly, allowing for rapid systemic distribution. It is not readily absorbed from the gastrointestinal tract, which limits its oral bioavailability. Once in the circulation, EDTA binds to metal ions and is excreted primarily via the kidneys. The half-life of EDTA varies based on the presence of chelated metals, but typically it is eliminated from the body within a few hours following administration. Renal function plays a significant role in the clearance of EDTA and its metal complexes.

Contra-indications

• Hypersensitivity to EDTA or any of its components
• Severe renal impairment
• Active bleeding disorders

Adverse effects

• Hypocalcemia
• Nausea
• Vomiting
• Diarrhea
• Fever
• Headache
• Thrombocytopenia
• Renal toxicity
• Cardiac arrhythmias

Interactions

• May enhance the effects of anticoagulants, leading to increased bleeding risk
• May interfere with the absorption of essential minerals such as calcium, magnesium, and zinc
• Caution with nephrotoxic agents due to potential additive renal toxicity

Precautions

• Use with caution in patients with renal impairment
• Monitor serum electrolytes, particularly calcium levels, during treatment
• Should not be administered rapidly due to risk of hypotension
• Not recommended for use in children unless supervised by a specialist

Pregnancy

The safety of EDTA in pregnancy has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

EDTA is excreted in breast milk. Caution should be exercised when administered to nursing mothers.

Storage

Store at room temperature, away from light, and moisture. Keep out of reach of children.

Formulations

• Intravenous solution
• Intramuscular injection
• Oral tablets

Indications

• Bacterial infections
• Respiratory tract infections
• Urinary tract infections
• Skin infections
• Gastrointestinal infections

Dosage

Children: Refer to the BNF for Children for appropriate dosing in paediatric patients.

Adults: Refer to the specific product guidelines for dosing information, as it can vary based on the indication and formulation used.

Mechanism of action

Enrofloxacin exerts its antibacterial effect through the inhibition of bacterial DNA gyrase and topoisomerase IV, which are essential enzymes for DNA replication and transcription. By interfering with these enzymes, enrofloxacin disrupts the normal function of the bacterial cell, leading to cell death.

Pharmacodynamics

Enrofloxacin has a bactericidal effect, meaning it kills bacteria rather than merely inhibiting their growth. Its activity is concentration-dependent, meaning that higher concentrations lead to more significant antibacterial effects. The drug has a broad spectrum of activity against many gram-negative bacteria, including Pseudomonas aeruginosa, as well as some gram-positive organisms.

Pharmacokinetics

Enrofloxacin is well-absorbed after oral administration, with peak plasma concentrations typically achieved within 1 to 2 hours. It is widely distributed throughout the body, including into tissues and fluids, and has good penetration into the central nervous system. The elimination half-life varies but is generally between 4 to 8 hours in humans. Enrofloxacin is primarily metabolized in the liver, and its metabolites, including ciprofloxacin, are also active against bacteria.

Contra-indications

• Hypersensitivity to enrofloxacin or any of its components
• Use in growing animals due to potential effects on cartilage development

Adverse effects

• Gastrointestinal disturbances such as vomiting and diarrhea
• Central nervous system effects including seizures and ataxia
• Tendon rupture or damage, particularly in larger breed dogs
• Possible cartilage damage in young animals

Interactions

• Antacids or products containing aluminum, magnesium, or iron may reduce the absorption of enrofloxacin
• Cationic agents may interfere with its antimicrobial activity
• Concurrent use with other nephrotoxic drugs may increase the risk of renal toxicity

Precautions

• Use with caution in animals with a history of seizures or renal impairment
• Monitor for signs of adverse reactions during therapy
• Not for use in animals with known hypersensitivity to fluoroquinolones

Pregnancy

Safety during pregnancy has not been established, use only if benefits outweigh risks.

Breast-feeding

Safety during lactation has not been fully established, use with caution.

Storage

Store in a cool, dry place, away from light. Keep out of reach of children.

Formulations

• Injectable solution
• Oral tablets
• Oral suspension

Dosage

Children: Refer to specific guidelines for pediatric dosing; consult the BNF for Children for accurate dosage information.

Adults: Refer to specific guidelines for use; dosage may vary based on the context of use.

Mechanism of action

Hydroxide ions act primarily as bases, neutralizing acids to form water and salts. They participate in various biochemical pathways, including selenium metabolism and the degradation of reactive oxygen species. Hydroxide can influence enzyme activity and stability by altering the pH of the environment, thereby affecting metabolic reactions.

Pharmacodynamics

Hydroxide ions can impact biological processes by changing the local pH, which influences enzyme activity, ion transport, and the solubility of other compounds. Their ability to neutralize acids can help regulate physiological pH, contributing to homeostasis in living organisms.

Pharmacokinetics

As an inorganic ion, hydroxide does not undergo traditional pharmacokinetic processes like absorption, distribution, metabolism, or excretion. Instead, it is rapidly equilibrated in biological fluids and participates in acid-base reactions, having immediate effects on the local environment.

Pregnancy

There is limited information regarding the use of hydroxide during pregnancy. Consult a healthcare professional for advice.

Breast-feeding

Limited data is available on the excretion of hydroxide in breast milk. Consult a healthcare professional before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Dosage

Children: Refer to specific drug formulations and product labels as purified substances can vary widely in their use and dosing.

Adults: Refer to specific drug formulations and product labels as purified substances can vary widely in their use and dosing.

Mechanism of action

The mechanism of action for purified compounds varies widely depending on the specific substance. Generally, purified drugs exert their effects by interacting with specific biological targets, such as receptors, enzymes, or ion channels, leading to a desired therapeutic effect. This interaction can involve binding to receptors to activate or inhibit signaling pathways, modulating enzymatic activity, or altering physiological processes.

Pharmacodynamics

Pharmacodynamics describes the effects of a drug on the body and the relationship between drug concentration and effect. For purified drugs, this can involve dose-response relationships and the time course of their action. The purified form often enhances potency and reduces variability in response among patients, which can lead to more predictable therapeutic outcomes. The overall effect is determined by the drug's affinity for its target, the efficacy of the drug-receptor interaction, and the downstream signaling pathways activated as a result of this interaction.

Pharmacokinetics

Pharmacokinetics involves the absorption, distribution, metabolism, and excretion (ADME) of a drug. For purified substances, absorption can be more efficient due to the absence of impurities that may affect solubility or stability. Distribution may also be enhanced, leading to higher bioavailability. Metabolism can be influenced by the structure of the purified compound, as it may be metabolized more readily by liver enzymes. Excretion typically occurs through the kidneys or liver, depending on the molecular characteristics of the purified drug.

Pregnancy

Consult with a healthcare professional, as the safety of purified forms of medications during pregnancy may vary depending on the specific substance.

Breast-feeding

Consult with a healthcare professional, as the safety of purified forms of medications during breastfeeding may vary depending on the specific substance.

Storage

Store in a cool, dry place, away from light and moisture, and keep out of reach of children.

Dosage

Children: Refer to the BNF for Children for specific dosing information.

Adults: Refer to the BNF for specific dosing information.

Mechanism of action

Sulfite acts as a reducing agent, participating in oxidation-reduction reactions within metabolic pathways. It is involved in the degradation of sulfur-containing compounds and aids in the reduction of sulfate to sulfide in certain anaerobic bacteria. This mechanism allows sulfite to influence energy metabolism and sulfur cycling in the environment.

Pharmacodynamics

Sulfite has various biological effects, including the modulation of cellular redox states and potential antioxidant properties. It can influence enzymatic activities, particularly those involving sulfite oxidase, which is responsible for the detoxification of sulfite to sulfate in mammals. Elevated levels of sulfite can lead to toxicity, particularly in individuals with sulfite sensitivity.

Pharmacokinetics

The pharmacokinetics of sulfite are not well characterized due to its varied natural occurrences and forms. In biological systems, sulfite is rapidly oxidized to sulfate, which is then excreted in the urine. The half-life and absorption characteristics depend on the route of exposure, whether through ingestion or inhalation. Individuals with compromised sulfite metabolism may experience increased retention of sulfite, leading to potential adverse reactions.

Pregnancy

Use during pregnancy is not well-studied; consult a healthcare provider.

Breast-feeding

Limited data available; consult a healthcare provider.

Storage

Store in a cool, dry place away from light.